AU2003297693A1 - Splice variant of human sodium iii channel (hnaiii18) - Google Patents

Splice variant of human sodium iii channel (hnaiii18)

Info

Publication number
AU2003297693A1
AU2003297693A1 AU2003297693A AU2003297693A AU2003297693A1 AU 2003297693 A1 AU2003297693 A1 AU 2003297693A1 AU 2003297693 A AU2003297693 A AU 2003297693A AU 2003297693 A AU2003297693 A AU 2003297693A AU 2003297693 A1 AU2003297693 A1 AU 2003297693A1
Authority
AU
Australia
Prior art keywords
hnaiii18
splice variant
human sodium
iii channel
sodium iii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003297693A
Other versions
AU2003297693A8 (en
Inventor
Dianne Hodges
Anja Kammesheidt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Euro Celtique SA
Original Assignee
Euro Celtique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique SA filed Critical Euro Celtique SA
Publication of AU2003297693A8 publication Critical patent/AU2003297693A8/en
Publication of AU2003297693A1 publication Critical patent/AU2003297693A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
AU2003297693A 2002-12-04 2003-12-04 Splice variant of human sodium iii channel (hnaiii18) Abandoned AU2003297693A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43179402P 2002-12-04 2002-12-04
US60/431,794 2002-12-04
PCT/US2003/038796 WO2004050857A2 (en) 2002-12-04 2003-12-04 Splice variant of human sodium iii channel (hnaiii18)

Publications (2)

Publication Number Publication Date
AU2003297693A8 AU2003297693A8 (en) 2004-06-23
AU2003297693A1 true AU2003297693A1 (en) 2004-06-23

Family

ID=32469613

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003297693A Abandoned AU2003297693A1 (en) 2002-12-04 2003-12-04 Splice variant of human sodium iii channel (hnaiii18)

Country Status (2)

Country Link
AU (1) AU2003297693A1 (en)
WO (1) WO2004050857A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005059101A2 (en) * 2003-12-12 2005-06-30 Wyeth Novel sodium channel
WO2006101629A2 (en) * 2005-02-17 2006-09-28 Vertex Pharmaceuticals Incorporated SODIUM CHANNEL PROTEIN TYPE III α-SUBUNIT SPLICE VARIANT
JP2013540130A (en) 2010-10-05 2013-10-31 パーデュー、ファーマ、リミテッド、パートナーシップ Quinazoline compounds as sodium channel blockers
US9181185B2 (en) 2011-10-31 2015-11-10 Purdue Pharma L.P. Heteroaryl compounds as sodium channel blockers
US9388137B2 (en) 2011-10-31 2016-07-12 Purdue Pharma L.P. Quaternized amines as sodium channel blockers
US9133131B2 (en) 2011-11-15 2015-09-15 Purdue Pharma L.P. Pyrimidine diol amides as sodium channel blockers
EP3666274A1 (en) 2013-03-15 2020-06-17 Purdue Pharma LP Carboxamide derivatives and use thereof
US9884865B2 (en) 2013-08-26 2018-02-06 Purdue Pharma L.P. Azaspiro[4.5] decane derivatives and use thereof
US9340504B2 (en) 2013-11-21 2016-05-17 Purdue Pharma L.P. Pyridine and piperidine derivatives as novel sodium channel blockers

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ296748A (en) * 1994-11-02 1999-11-29 Univ New York State Res Found Peripheral nervous system specific sodium channel proteins, DNA coding therefor, compositions and methods

Also Published As

Publication number Publication date
WO2004050857A2 (en) 2004-06-17
AU2003297693A8 (en) 2004-06-23
WO2004050857A3 (en) 2005-03-17

Similar Documents

Publication Publication Date Title
AU2003250690A1 (en) Auto-characterization of optical devices
AU2003298738A1 (en) Liposomal formulations
AU2003274446A1 (en) Disposable mini-applications
AU2003205950A1 (en) Placement of alternative advertisements
AU2003248122A1 (en) Sodium channel inhibitor
AU2003283033A1 (en) Optical multiplexer
AU2003267638A1 (en) Endoscope
AU2003230401A1 (en) Bis-benzimidazoles and related compounds as potassium channel modulators
AU2003229352A1 (en) Improvement of low loss optical material
AU2002236775A1 (en) Sodium channel modulators
AU2003279911A1 (en) Therapeutic formulations
AU2003277596A1 (en) Method of deuterization
AU2003297693A1 (en) Splice variant of human sodium iii channel (hnaiii18)
WO2005033343A8 (en) Novel splice variants of human dkkl1
AUPS096002A0 (en) Method of construction
AU2003219580A1 (en) Novel therapeutical use of byakangelicin
AU2003295790A1 (en) Modulation of iap-like expression
AU2003298671A1 (en) Modulation of notch3 expression
AU2003282437A1 (en) Crutch
AU2003229459A1 (en) Methods of using thiazolidinedithione derivatives
AU2003298725A1 (en) Preparation of metallotexaphyrins
AU2003212010A1 (en) Laryngoscope
AU2003262152A1 (en) Endoscope
AU2003248481A1 (en) Doctor underpants
AU2003234867A1 (en) Rollator

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase